Comments
Loading...
Lifeline Biotechnologies Analyst Ratings and Price Targets | OTC:LLBO | Benzinga
Lifeline Biotechnologies Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Lifeline Biotechnologies Corp from these most-recent analyst ratings.
Analyst Ratings for Lifeline Biotechnologies
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Lifeline Biotechnologies (LLBO) stock?
There is no price target for Lifeline Biotechnologies
What is the most recent analyst rating for Lifeline Biotechnologies (LLBO)?
There is no analyst for Lifeline Biotechnologies
When was the last upgrade for Lifeline Biotechnologies (LLBO)?
There is no last upgrade for Lifeline Biotechnologies
When was the last downgrade for Lifeline Biotechnologies (LLBO)?
There is no last downgrade for Lifeline Biotechnologies.
When is the next analyst rating going to be posted or updated for Lifeline Biotechnologies (LLBO)?
There is no next analyst rating for Lifeline Biotechnologies.
Is the Analyst Rating Lifeline Biotechnologies (LLBO) correct?
There is no next analyst rating for Lifeline Biotechnologies.
Browse analyst ratings and price targets on all stocks.
